Evidence map›Paper›PMID 26109207›Full record

ReviewClinical journal of the American Society of Nephrology : CJASN2015

Mild Chronic Hyponatremia in the Ambulatory Setting: Significance and Management.

Helbert Rondon-Berrios, Tomas Berl

Registry-linked trialAbstract readReview
In one paragraph

Review in Clinical journal of the American Society of Nephrology : CJASN, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04588207 (Urea for Chronic Hyponatremia), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04588207 phase2terminatednot on this mapstarted 2021, after this paper: background citation

Urea for Chronic Hyponatremia: A Pilot Study

TypeinterventionalSponsorHelbert Rondon Berrios, MD, MSRan2021 to 2022Enrolled2ConditionsHyponatremia, Inappropriate ADH SyndromeArmsUrea
3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Oxcarbazepine and Hyponatremia.Medicina (Kaunas, Lithuania) · 2022
    Article
  10. Article
  11. Hyponatremia and Oxidative Stress.Antioxidants (Basel, Switzerland) · 2021
    Review
  12. Article
  13. Review
  14. Observational
  15. Review
  16. Article
  17. Article
  18. Prevalence of hyponatremia in inpatients with incurable and life-limiting diseases and its association with physical symptoms-a retrospective descriptive study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2018
    Article
  19. Review
  20. Hyponatremia in solid-tumor cancer patients: uncertainty regarding the use of vaptans.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Helbert Rondon-BerriosRenal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; and rondonberriosh@upmc.edu.
Tomas BerlDivision of Renal Diseases and Hypertension, University of Colorado School of Medicine, Aurora, Colorado.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mild chronic hyponatremia, as defined by a persistent (>72 hours) plasma sodium concentration between 125 and 135 mEq/L without apparent symptoms, is common in ambulatory patients and generally perceived as being inconsequential. The association between increased mortality and hyponatremia in hospitalized patients in various settings and etiologies is widely recognized. This review analyzes the significance of mild chronic hyponatremia in ambulatory subjects and its effects on mortality and morbidity. It addresses whether this disorder should even be treated and if so, which patients are likely to benefit from treatment. The available approaches to correct hyponatremia in such patients in the context of recently published panel-generated recommendations and guidelines are described.

Indexed as

Ambulatory CareBiomarkersChronic DiseaseHumansHyponatremiaRisk AssessmentRisk FactorsSeverity of Illness IndexSodiumTreatment OutcomeBiomarkersSodiumhyponatremiamorbiditymortalitytolvaptanurea

Identifiers

PMID26109207
PMCPMC4670756

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.